Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I found this statement in the results intriguing
"In collaboration with DSM a trial batch of Fruitflow+ nitrates development products was manufactured during the year and sold to DSM."
Who did the selling ? Did DSM sell to itself ? Who supplied the nitrates ? SiS ?
W?
Yep, although I doubt anyone here has been invested from the formation of Provexis.
Your Sunday 12.03 post does say exactly that, and even suggests a mark up, I think that's why myself and gixer sought to clarify. All makes zero difference to the outcome, that's be down to the completion of studies and what effect they have on the opinions of health professionals. If there can be a proven link to aiding recovery from Covid symptoms, then Wellsite's comment that Fruitflow may be too big for Provexis to handle may well be highly viable IMHO
Well to be fair Alf, I'd never said we should be responsible for the manufacturing side, and that's what you seemed to be suggesting I had said.
Fair enough if we see things in a different way, but at least try to deal with people's opinions rather than things they haven't said.
Not sure why BB is taking umbridge though, just a few people bored senseless, having a chat after 15+ years of waiting...
..and all I said was it seemed an illogical position.
Polish that badge BB
:-)
Strange the links didn't work so try this.
https://bit.ly/3EsCCmZ
https://bit.ly/3xZPYV3
Evaluation of the equivalence of different intakes of Fruitflow in affecting platelet aggregation and thrombin generation capacity in a randomized, double-blinded pilot study in male subjects.
https://bm****r.biomedcentral.com/articles/10.1186/s40795-021-00485-5
Peer Review reports
https://bm****r.biomedcentral.com/articles/10.1186/s40795-021-00485-5/peer-review
BB,
"negative" no
"paranoid" no
But if Barbershop, or anyone else, feels like I have jumped down his/her throat because I simply disagreed with there statement then I apologise. It was not my intention to come across that way.
As we have already agreed to disagree I am unsure why you feel the need to bring it up again but my opinion, rightly or wrongly remains the same.
As Provexis is responsible for the manufacture, supply and sale of Fruitflow to By-Health I don't see how they can be classed as the middleman.
Does it matter either way? No.
Seems to me that some people are jumping down a poster's throat because they perceived the term "middleman" as negative and took umbrage at that.
If you own the IP, and act as a middleman, that's actually acknowledging your limitations and, almost certainly, maximising your returns. But if you're a bit paranoid about stuff posted, you might not see it like that.
See also https://dictionary.cambridge.org/dictionary/english/middleman
BB
lol, BH would own the IP by then
W£
Allowing the Chinese to produce their own is laying PXS open to be defrauded imo. Everyone knows just how much IP they have stolen already . Look at KETL they spend millions suing those that nick their IP.
Fair enough.
Hopefully next few years will start to see some kind of turnaround in outlook.
Well we will have to agree to disagree on this one.
As for "salting it", I am only stating how I see it.
One thing that is for sure is all the profit will go directly to Provexis from By-Health sales, not split with DSM and there share would have been more than 10%
No one mentioned or suggested generics Gixer, we all know we're talking about FF and that we have patent protection.
Not sure why you and Alfista can't respond to what people are saying without salting it.
This is what I'm seeing from Provexis scope:
manufacturer (3rd party) >>supplier(Provexis)>>Customer(ByHealth)
Seems to put us in the middle.
You might well say that ByHealth then sell on again in various formats, but it's outside our scope in the terms of the supply chain.
I thin that would be bad practice, as it would hand too much control to BH, making it difficult for to separate at the end of the agreement/contract term. Much better if PXS maintain production control and use a third party to produce it. Also they will benefit from economies of scale. Stephen Moon once said that with increased production, the margin goes from good to very high.
Longer term I expect By Health shall set up their own in country FF production
- makes sense as China is the biggest tomato producer
https://edis.ifas.ufl.edu/publication/FE1027
W$
Fruitflow is currently produced by outsourced third party manufacturers in Europe, and it is intended that the Company will have direct access to these manufacturers for its sales of Fruitflow to third parties. The Company and the third party manufacturers are actively engaged in some ongoing production capacity planning, looking at the steps required to scale-up the production of Fruitflow to meet the anticipated increase in demand.
You make it sound like Provexis is buying and selling some generic product like vitamin c. It's not.
Indena is a contract manufacturer and would be manufacturing Fruitflow under contract for Provexis. As though pxs was manufacturing it themselves.
So, to change my first thought. If there is a middleman then that would be By-health as they are buying from the owner and selling on.
Alf, I never suggested we would manufacture ourselves, again, I have no idea where that comes from when I'd say we could buy it from a third party....
If we are responsible for supplying something that someone else manufactures to byhealth, seems to out us in the middle of that chain to me, but there you go, everyone has their own take on it...
Just my opinion but if there is a middle man then surely that would be the manufacturer. Its certainly not provexis.
Well, your previous post, calling Provexis the "middle men".
Even if Provexis expand demand vastly, it will always be more cost effective to use a specialist to make it, but that doesnt make it a "middle man" operation IMHO
Who's suggesting that Alf? Not sure where it's coming from.
That doesn't seem logical to me. Are you suggesting that Provexis should move from their business model of mainly being responsible for developing and maintaining IP and patents, to a specialist manufacturer of the product? How much would that cost, how would a factory be run when production is only required a few times per year?
Was only suggesting we would use a third party for the manufacture...ok so it might not be DSM, still sounds like man in the middle to me...
Just for info in case anyone is not aware.
DSM does not manufacture Fruitflow but instead has a company in Italy/France to do this work and they are called Indena SAS.
Not saying this is were Provexis will have it manufactured but they are already set up and we will not have to go through DSM to buy it.